| Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study COVIDSurg Collaborative Anaesthesia 76 (6), 748-758, 2021 | 585* | 2021 |
| Anxiety: There is an app for that. A systematic review of anxiety apps M Sucala, P Cuijpers, F Muench, R Cardoș, R Soflau, A Dobrean, ... Depression and anxiety 34 (6), 518-525, 2017 | 225 | 2017 |
| Multiple primary malignancies-epidemiological analysis at a single tertiary institution. A Irimie, P Achimas-Cadariu, C Burz, E Puscas Journal of Gastrointestinal & Liver Diseases 19 (1), 2010 | 131 | 2010 |
| Clinical and pathological implications of miRNA in bladder cancer C Braicu, R Cojocneanu-Petric, S Chira, A Truta, A Floares, B Petrut, ... International journal of nanomedicine, 791-800, 2015 | 118 | 2015 |
| SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study. C COVIDSurg, C GlobalSurg Anaesthesia 77 (1), 28-39, 2022 | 109 | 2022 |
| The role of medical registries, potential applications and limitations B Pop, B Fetica, ML Blaga, AP Trifa, P Achimas-Cadariu, CI Vlad, ... Medicine and pharmacy reports 92 (1), 7, 2019 | 99 | 2019 |
| SERS-based differential diagnosis between multiple solid malignancies: Breast, colorectal, lung, ovarian and oral cancer V Moisoiu, A Stefancu, D Gulei, R Boitor, L Magdo, L Raduly, S Pasca, ... International journal of nanomedicine, 6165-6178, 2019 | 76 | 2019 |
| miRNA expression profiling in formalin-fixed paraffin-embedded endometriosis and ovarian cancer samples OL Braicu, L Budisan, R Buiga, A Jurj, P Achimas-Cadariu, LA Pop, ... OncoTargets and therapy, 4225-4238, 2017 | 60 | 2017 |
| Aberrant miRNAs expressed in HER-2 negative breast cancers patient C Braicu, L Raduly, G Morar-Bolba, R Cojocneanu, A Jurj, LA Pop, ... Journal of Experimental & Clinical Cancer Research 37, 1-16, 2018 | 51 | 2018 |
| The role of ketamine in the treatment of chronic cancer pain AO Zgaia, A Irimie, D Sandesc, C Vlad, C Lisencu, A Rogobete, ... Clujul Medical 88 (4), 457, 2015 | 50 | 2015 |
| Novel insight into triple-negative breast cancers, the emerging role of angiogenesis, and antiangiogenic therapy C Braicu, R Chiorean, A Irimie, S Chira, C Tomuleasa, E Neagoe, ... Expert reviews in molecular medicine 18, e18, 2016 | 46 | 2016 |
| Effects of pre‐operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study COVIDSurg Collaborative, GlobalSurg Collaborative, D Nepogodiev, ... Anaesthesia 76 (11), 1454-1464, 2021 | 45 | 2021 |
| The prognostic value of FOXP3+ T regulatory cells in colorectal cancer C Vlad, P Kubelac, B Fetica, D Vlad, A Irimie, P Achimas-Cadariu J buon 20 (1), 114-9, 2015 | 45 | 2015 |
| The prognostic value of the Na+/H+ exchanger regulatory factor 1 (NHERF1) protein in cancer C Saponaro, A Malfettone, TS Dell'Endice, AE Brunetti, ... Cancer Biomarkers 14 (2-3), 177-184, 2014 | 41 | 2014 |
| Caffeic acid phenethyl ester activates pro-apoptotic and epithelial–mesenchymal transition-related genes in ovarian cancer cells A2780 and A2780cis C Gherman, OL Braicu, O Zanoaga, A Jurj, V Pileczki, M Maralani, ... Molecular and cellular biochemistry 413, 189-198, 2016 | 38 | 2016 |
| Dual targeted therapy with p53 siRNA and Epigallocatechingallate in a triple negative breast cancer cell model C Braicu, V Pileczki, L Pop, RC Petric, S Chira, E Pointiere, ... PLoS One 10 (4), e0120936, 2015 | 38 | 2015 |
| Tumor infiltrating lymphocytes as a prognostic factor in malignant melanoma. Review of the literature VA Gata, CI Lisencu, CI Vlad, D Piciu, A Irimie, P Achimas-Cadariu J. BUON 22 (3), 592-598, 2017 | 34 | 2017 |
| Expression III: patients’ expectations and preferences regarding physician–patient relationship and clinical management—results of the international NOGGO/ENGOT-ov4-GCIG study … G Oskay-Özcelik, S Alavi, R Richter, M Keller, R Chekerov, SC Cecere, ... Annals of Oncology 29 (4), 910-916, 2018 | 30 | 2018 |
| Fertility preservation in Hodgkin’s lymphoma patients that undergo targeted molecular therapies: an important step forward from the chemotherapy era A Traila, D Dima, P Achimas-Cadariu, R Micu Cancer management and research, 1517-1526, 2018 | 28 | 2018 |
| MiRNA-based therapeutics in oncology, realities, and challenges O Balacescu, S Visan, O Baldasici, L Balacescu, C Vlad, ... Antisense Ther 15, 1-27, 2019 | 27 | 2019 |
